Literature DB >> 7797239

Recognition sites on human IgG for Fc gamma receptors: the role of glycosylation.

R Jefferis1, J Lund, M Goodall.   

Abstract

Human IgG subclass proteins exhibit more than 95% primary amino acid sequence homology in their Fc regions, but each has a unique profile for recognition by the 3 human Fc gamma receptors. The Fc gamma Rs are themselves highly homologous members of the immunoglobulin supergene family. Consistent with these data we have proposed that Fc gamma RI, Fc gamma RII and Fc gamma RIII recognise overlapping non-identical interaction sites in the lower hinge region of the CH2 domain of the IgG molecule. Evidence in support was provided by protein engineering effecting single amino acid replacements in the proposed site. Alternatively, we have demonstrated that the primary amino acid sequence alone is not sufficient for IgG molecules to fold with the generation of Fc gamma R interaction sites and that glycosylation of Asn 297 of the CH2 domain is essential. We have further defined a 'core' oligosaccharide structure that provides for the generation of Fc gamma R interaction sites which suggests that the addition of outer-arm sugar residues does not affect this primary activity; although in vivo it could influence other essential biological activities. These findings have opened up a new approach to engineering antibody function--by protein engineering of amino acid residues that form contacts with the oligosaccharide moiety. In the present report we demonstrate that replacement of contact residues for galactose on the alpha(1-6) arm does not affect Fc gamma RI and Fc gamma RII recognition while replacement of Asp 265, a contact for a 'core' N-acetylglucosamine residue, results in a loss of Fc gamma RI and Fc gamma RII recognition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797239     DOI: 10.1016/0165-2478(94)00201-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

Review 1.  The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection.

Authors:  Kimberly A Thomas; Nicole M Valenzuela; Elaine F Reed
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

2.  Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity.

Authors:  Stefanie Derer; Pia Glorius; Martin Schlaeth; Stefan Lohse; Katja Klausz; Umesh Muchhal; John R Desjarlais; Andreas Humpe; Thomas Valerius; Matthias Peipp
Journal:  MAbs       Date:  2013-12-11       Impact factor: 5.857

Review 3.  Induction of immunity to human immunodeficiency virus type-1 by vaccination.

Authors:  M Juliana McElrath; Barton F Haynes
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

4.  Binding site on human immunoglobulin G for the affinity ligand HWRGWV.

Authors:  Haiou Yang; Patrick V Gurgel; D Keith Williams; Benjamin G Bobay; John Cavanagh; David C Muddiman; Ruben G Carbonell
Journal:  J Mol Recognit       Date:  2010 May-Jun       Impact factor: 2.137

Review 5.  The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis.

Authors:  Andrea Mastrangelo; Tania Colasanti; Cristiana Barbati; Arbi Pecani; Danilo Sabatinelli; Monica Pendolino; Simona Truglia; Laura Massaro; Riccardo Mancini; Francesca Miranda; Francesca Romana Spinelli; Fabrizio Conti; Cristiano Alessandri
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

Review 6.  Fc gamma receptors: glycobiology and therapeutic prospects.

Authors:  Jerrard M Hayes; Mark R Wormald; Pauline M Rudd; Gavin P Davey
Journal:  J Inflamm Res       Date:  2016-11-16

7.  Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.

Authors:  Tetyana Dashivets; Marco Thomann; Petra Rueger; Alexander Knaupp; Johannes Buchner; Tilman Schlothauer
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.